Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats

Author： Besse S. Tanguy S. Riou B. Boucher F. Bulteau A.-L. Le Page C. Swynghedauw B. de Leiris J.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.432, Iss.2, 2001-12, pp. : 167-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bosentan: a dual endothelin receptor antagonist

By Roux Sébastien Rubin Lewis J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 991-1002

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist

By Jasper Dingemanse Paul L.M. van Giersbergen

Clinical Pharmacokinetics, Vol. 43, Iss. 15, 2004-01 ,pp. : 1089-1115

Adis International

Access to resources Recommend Favorite

Thimerosal Attenuates Ischaemia-Reperfusion Arrhythmias in Rats: No Modification by Anti-Ischaemic Agent Trimetazidine or Endothelin Receptor Antagonist Bosentan

By Iskit A.B. Oguz Guc M.

Pharmacological Research, Vol. 34, Iss. 1, 1996-07 ,pp. : 17-23

Academic Press

Access to resources Recommend Favorite

Bosentan, a dual endothelin receptor antagonist, activates the pregnane X nuclear receptor

By van Giersbergen P.L.M. Gnerre C. Treiber A. Dingemanse J. Meyer U.A.

European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

The endothelin receptor antagonist bosentan [`Tracleer'; Actelion] has been approved in Canada

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite